These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8989924)

  • 1. Effects of in vivo culture of murine mammary adenocarcinoma cells on tumor and metastatic growth.
    Aguirre Ghiso J; Diament M; D'elia I; Bal de Kier Joffé E; Klein S
    Tumour Biol; 1997; 18(1):41-52. PubMed ID: 8989924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator activity increases during the growth of two murine mammary adenocarcinomas with different metastasizing abilities.
    Pereyra-Alfonso S; Solarz GR; Bal de Kier Joffé E
    Clin Exp Metastasis; 1992 Nov; 10(6):395-401. PubMed ID: 1451349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.
    Guerra FK; Eijan AM; Puricelli L; Alonso DF; Bal de Kier Joffé E; Kornblihgtt AR; Charreau EH; Elizalde PV
    Int J Cancer; 1996 Mar; 65(6):812-20. PubMed ID: 8631597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas.
    Pereyra-Alfonso S; Haedo A; Bal de Kier Joffé E
    Int J Cancer; 1988 Jul; 42(1):59-63. PubMed ID: 3134309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a fibroblastoid mammary carcinoma cell line (LM2) originated from a mouse adenocarcinoma.
    Galli S; Colombo L; Vanzuli S; Daroqui MC; del Carmen Vidal M; Jasnis MA; Sacerdote de Lustig E; Eijan AM
    Int J Oncol; 2000 Dec; 17(6):1259-65. PubMed ID: 11078814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model.
    Bumaschny V; Urtreger A; Diament M; Krasnapolski M; Fiszman G; Klein S; Joffé EB
    Breast Cancer Res; 2004; 6(2):R116-29. PubMed ID: 14979922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of host-organ environment on the in vivo and in vitro behavior of a murine mammary adenocarcinoma.
    Puricelli L; Gómez DE; Vidal MC; Eiján AM; Spinelli O; Alonso DF; de Lustig ES; Bal de Kier Joffé E
    Tumour Biol; 1994; 15(5):284-93. PubMed ID: 7991989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isologous and heterologous platelet aggregation induced by tumor cells from three murine mammary gland adenocarcinomas with different metastatic abilities.
    Pasqualini ME; Eynard AR
    Exp Toxicol Pathol; 1994 Feb; 45(7):449-51. PubMed ID: 8167468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-chain, urokinase-type plasminogen activator in a tumor model linked to metastatic potential.
    Kellen JA; Mirakian A; Wong A
    In Vivo; 1988; 2(2):155-7. PubMed ID: 2979833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
    Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential.
    Di Carlo E; Modesti A; Castrilli G; Landuzzi L; Allione A; de Giovanni C; Musso T; Musiani P
    J Pathol; 1997 May; 182(1):76-85. PubMed ID: 9227345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of fibrinolysis during the growth of two murine mammary adenocarcinomas.
    Alonso DF; Farías EF; Bal de Kier Joffé E
    Cancer Lett; 1993 Jul; 70(3):181-7. PubMed ID: 8353814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-metastatic clones selected in vitro from a recent spontaneous BALB/c mammary adenocarcinoma cell line.
    Lollini PL; de Giovanni C; Eusebi V; Nicoletti G; Prodi G; Nanni P
    Clin Exp Metastasis; 1984; 2(3):251-9. PubMed ID: 6543703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
    Kwon YS; Lee KS; Chun SY; Jang TJ; Nam KS
    Int J Oncol; 2016 Jul; 49(1):336-42. PubMed ID: 27176787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of plasmatic fibronectin in mice bearing adenocarcinomas of different metastasizing ability.
    Puricelli L; Bal de Kier Joffé E; Eiján AM; Entín D; de Lustig ES
    Cancer Lett; 1985 Nov; 29(2):189-95. PubMed ID: 4075288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
    Wilson MJ; Sinha AA
    Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-site dependence for the production of urokinase-type plasminogen activator and metastasis by human renal cell carcinoma cells.
    Gohji K; Nakajima M; Boyd D; Dinney CP; Bucana CD; Kitazana S; Kamidono S; Fidler IJ
    Am J Pathol; 1997 Dec; 151(6):1655-61. PubMed ID: 9403716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
    Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF
    Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.